Stevanato Group S.p.A.
STVN64
$19.31arrow_drop_down6.19%-$1.26
High Growth
STVN64
$19.31
arrow_drop_down6.19%Performance History
| Key Stats | |
|---|---|
| Open | $20.50 |
| Prev. Close | $20.50 |
| EPS | 0.46 |
| Next Earnings Date | May 15, 2025 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 20.50 | 20.50 |
| 52 Week Range | 16.56 | 35.56 |
| Ratios | |
|---|---|
| EPS | 0.46 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Stevanato Group S.p.A. (STVN)
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- CEO
- Mr. Franco Moro
- Headquarters
- Piombino Dese
- Employees
- 5260
- Exchange
- NYSE
Keep an eye on Stevanato Group S.p.A.
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Stevanato Group S.p.A.'s (STVN) price per share?
The current price per share for Stevanato Group S.p.A. (STVN) is $19.32. The stock has seen a price change of -$1.27 recently, indicating a -6.2% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Stevanato Group S.p.A. (STVN)?
For Stevanato Group S.p.A. (STVN), the 52-week high is $35.56, which is 84.11% from the current price. The 52-week low is $16.56, the current price is 16.64% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Stevanato Group S.p.A. (STVN) a growth stock?
Stevanato Group S.p.A. (STVN) has shown an average price growth of -4.94% over the past three years. It has received a score of 65 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Stevanato Group S.p.A. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Stevanato Group S.p.A. (STVN) stock price performance year to date (YTD)?
As of the latest data, Stevanato Group S.p.A. (STVN) has a year-to-date price change of -27.31%. Over the past month, the stock has experienced a price change of 5.6%. Over the last three months, the change has been -3.04%. Over the past six months, the figure is -9.49%.
help
Is Stevanato Group S.p.A. (STVN) a profitable company?
Stevanato Group S.p.A. (STVN) has a net income of $142.65M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 30.05% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 14.99% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.06B, with a revenue growth rate of 8.07%, providing insight into the company's sales performance and growth. The gross profit is $319.43M. Operating income is noted at $186.4M. Furthermore, the EBITDA is $283.5M.
help
What is the market capitalization of Stevanato Group S.p.A. (STVN)?
Stevanato Group S.p.A. (STVN) has a market capitalization of $5.53B. The average daily trading volume is 19.84, indicating the stock's liquidity and investor engagement.
News
DUAL CHAMBER PREFILLED SYRINGES
BIOLOGICS
BIOSIMILARS
DRUG DELIVERY
Dual Chamber Prefilled Syringes Market Size is Projected to Reach US$ 5,495.5 Million by 2034 | Fact.MR
May 20, 2024
USNA vs. STVN: Which Stock Should Value Investors Buy Now?
May 2, 2024
USNA or STVN: Which Is the Better Value Stock Right Now?
May 2, 2024
Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Apr 25, 2024
Stevanato Group (STVN) to Report Q1 Results: What You Should Expect
Mar 11, 2024
TAK or STVN: Which Is the Better Value Stock Right Now?